SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus

Go back to SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus

SurModics (SRDX) PT Lowered to $69 at Needham & Company

January 31, 2019 8:26 AM EST

Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining a Buy rating.

Matson commented, "RDX beat consensus F1Q19 revenue and EPS estimates. Management raised the lower end of its FY19 revenue guidance and narrowed... More